Total Payments
$6,425
2024 Payments
$981.23
Companies
32
Transactions
243
Medicare Patients
11,523
Medicare Billing
$384,797
Payment Breakdown by Category
Food & Beverage$6,331 (98.5%)
Education$94.00 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,331 | 242 | 98.5% |
| Education | $94.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,371 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $834.93 | 34 | $0 (2024) |
| ABBVIE INC. | $641.87 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $532.60 | 7 | $0 (2022) |
| Lilly USA, LLC | $472.42 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $332.86 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $312.86 | 8 | $0 (2024) |
| Amgen Inc. | $249.99 | 2 | $0 (2023) |
| Amarin Pharma Inc. | $227.14 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $170.00 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $981.23 | 52 | Novo Nordisk Inc ($264.31) |
| 2023 | $1,790 | 72 | AstraZeneca Pharmaceuticals LP ($257.21) |
| 2022 | $2,142 | 61 | Novo Nordisk Inc ($640.62) |
| 2021 | $1,512 | 58 | Novo Nordisk Inc ($244.28) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Obesity | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Biological | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Obesity | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 09/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Biological | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Obesity | ||||||
| 07/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,570 | 4,294 | $319,575 | $87,770 |
| 2022 | 20 | 2,477 | 3,869 | $302,099 | $84,502 |
| 2021 | 21 | 3,143 | 5,889 | $391,181 | $105,901 |
| 2020 | 24 | 3,333 | 6,617 | $423,643 | $106,624 |
Total Patients
11,523
Total Services
20,669
Medicare Billing
$384,797
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 438 | $98,550 | $31,350 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $42,625 | $13,628 | 32.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 169 | 267 | $33,375 | $7,746 | 23.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 170 | 286 | $20,306 | $4,708 | 23.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 172 | 287 | $18,368 | $4,242 | 23.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 169 | 272 | $15,504 | $3,569 | 23.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 158 | 240 | $15,120 | $3,458 | 22.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 171 | 302 | $13,590 | $3,126 | 23.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 182 | 335 | $3,015 | $2,814 | 93.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 171 | 285 | $11,685 | $2,713 | 23.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 171 | 287 | $11,193 | $2,537 | 22.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 171 | 289 | $9,537 | $2,199 | 23.1% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 170 | 292 | $8,176 | $1,863 | 22.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 113 | 154 | $3,080 | $940.94 | 30.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 99 | $7,425 | $858.48 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $2,295 | $777.21 | 33.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 125 | 186 | $1,860 | $409.20 | 22.0% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 13 | 13 | $1,417 | $328.77 | 23.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 16 | 16 | $992.00 | $302.72 | 30.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 34 | 94 | $658.00 | $102.73 | 15.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $804.00 | $97.80 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 466 | $104,850 | $34,811 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $39,897 | $12,987 | 32.6% |
| 82306 | Vitamin d-3 level | Office | 2022 | 166 | 252 | $31,500 | $7,379 | 23.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 169 | 258 | $18,318 | $4,287 | 23.4% |
About Myra Downing-Sherman, ARNP
Myra Downing-Sherman, ARNP is a Family healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497797344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Myra Downing-Sherman, ARNP has received a total of $6,425 in payments from pharmaceutical and medical device companies, with $981.23 received in 2024. These payments were reported across 243 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,331).
As a Medicare-enrolled provider, Downing-Sherman has provided services to 11,523 Medicare beneficiaries, totaling 20,669 services with total Medicare billing of $384,797. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Ocala, FL
- Active Since 06/12/2006
- Last Updated 02/09/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1497797344
Products in Payments
- Rybelsus (Drug) $595.76
- XARELTO (Drug) $532.60
- FARXIGA (Drug) $474.08
- Ozempic (Drug) $451.79
- JARDIANCE (Drug) $381.40
- BREZTRI (Drug) $266.70
- MOUNJARO (Drug) $256.74
- Repatha (Biological) $249.99
- UBRELVY (Drug) $234.56
- Vascepa (Drug) $227.14
- QULIPTA (Drug) $171.53
- VRAYLAR (Drug) $171.40
- REXULTI (Drug) $169.45
- RYBELSUS (Drug) $164.91
- Wegovy (Drug) $158.91
- INTERSTIM (Device) $153.02
- TRELEGY ELLIPTA (Drug) $152.01
- Veozah (Drug) $149.96
- PAINTEQ (Device) $146.87
- ELIQUIS (Drug) $139.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ocala
Nicole Stephens, Aprn, APRN
Family — Payments: $11,721
Family $11,721
Lilia Aguila, Aprn, APRN
Family — Payments: $9,531
Family $9,531
Joda Picard, Aprn, APRN
Family — Payments: $7,860
Family $7,860
Katelyn Tello, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $7,362
Family $7,362
Mrs. Kimberly Fiscus, Arnp, ARNP
Family — Payments: $6,760
Family $6,760
Angelika Agudelo, Np-C, NP-C
Family — Payments: $6,608
Family $6,608